NextCure, Inc. Common Stock (NXTC) is a publicly traded Healthcare sector company. As of November 9, 2026, NXTC trades at $5.66 with a market cap of $24.49M and a P/E ratio of -0.33. NXTC moved +15.95% today. Year to date, NXTC is -52.85%; over the trailing twelve months it is -30.11%. Its 52-week range spans $1.55 to $15.74. Analyst consensus is buy with an average price target of $20.00. Rallies surfaces NXTC's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for NXTC combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $5.66 |
| Market Cap | $24.49M |
| P/E Ratio | -0.33 |
| EPS | $-19.65 |
| Dividend Yield | 0.00% |
| 52-Week High | $15.74 |
| 52-Week Low | $1.55 |
| Volume | 57.11K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-55.84M |
| Gross Margin | 0.00% |
1 analysts cover NXTC: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $20.00.